Gastrointestinal STRING Test With Oral Immunotherapy (STRING)
Monitoring Gastrointestinal Responses In Food Oral Immunotherapy Using the Esophageal STRING Test
Sponsor: Stanford University
Terminated
Parent study closed to enrollment
Listed as NCT04943744, this EARLY_PHASE1 trial focuses on Eosinophilic Disorder and Food Allergy and remains terminated or withdrawn. Sponsored by Stanford University, it has been updated 10 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Oct 2024 — Present [monthly]
Terminated EARLY_PHASE1
Phase: PHASE1 → EARLY_PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Terminated PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Terminated PHASE1
Status: Enrolling By Invitation → Terminated · Phase: None → PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Enrolling By Invitation
-
Dec 2023 — Jul 2024 [monthly]
Enrolling By Invitation
▶ Show 5 earlier versions
-
Dec 2022 — Dec 2023 [monthly]
Enrolling By Invitation
-
Sep 2022 — Dec 2022 [monthly]
Enrolling By Invitation
-
Dec 2021 — Sep 2022 [monthly]
Enrolling By Invitation
-
Oct 2021 — Dec 2021 [monthly]
Enrolling By Invitation
-
Sep 2021 — Oct 2021 [monthly]
Enrolling By Invitation
First recorded
May 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .